Dr Joanne Euden

(hi/ei)

2025

• Henley, J. et al. 2025. Procalcitonin to guide antibiotic use during the first wave of COVID-19 in English and Welsh hospitals: integration and triangulation of findings from quantitative and qualitative sources. BMJ Open 15, article number: e093210. (10.1136/bmjopen-2024-093210)
• Varley, M. et al. 2025. Adaptive clinical trial of AZD7442 and SARS-CoV-2 vaccination in immunosuppressed patients highly vulnerable to infection with SARS-CoV-2 virus (RAPID-PROTECTION): protocol for a multicentre, interventional open-label, randomised controlled trial.. BMJ Open 15(1), article number: e084345. (10.1136/bmjopen-2024-084345)

2024

• Sandoe, J. A. T. et al. 2024. A retrospective propensity-score-matched cohort study of the impact of procalcitonin testing on antibiotic use in hospitalized patients during the first wave of COVID-19. Journal of Antimicrobial Chemotherapy 79(11), pp. 2792-2800., article number: dkae246. (10.1093/jac/dkae246)
• Webb, E. J. D. et al. 2024. The cost-effectiveness of procalcitonin for guiding antibiotic prescribing in individuals hospitalized with COVID-19: part of the PEACH study. Journal of Antimicrobial Chemotherapy 79(8), pp. 1831-1842., article number: dkae167. (10.1093/jac/dkae167)
• Webb, E. J. D. et al. 2024. Evidence of quality of life for hospitalised patients with COVID-19: a scoping review. Health Technology Assessment (10.3310/ATPR4281)

2023

• Henley, J. et al. 2023. Developing a model for decision-making around antibiotic prescribing for patients with COVID-19 pneumonia in acute NHS hospitals during the first wave of the COVID-19 pandemic: Qualitative results from the Procalcitonin Evaluation of Antibiotic use in COVID-19 Hospitalised patients (PEACH Study). BMJ Open 13(12), article number: e077117. (10.1136/bmjopen-2023-077117)
• Little, P. et al. 2023. Antibiotics for lower respiratory tract infection in children presenting in primary care: ARTIC-PC RCT. Health Technology Assessment 27, article number: 9. (10.3310/DGBV3199)

2022

• Euden, J. et al. 2022. Procalcitonin evaluation of antibiotic use in COVID-19 hospitalised patients (PEACH): protocol for a retrospective observational study. Methods and Protocols 5(6), article number: 95. (10.3390/mps5060095)
• Chatoo, S. A., Thomas-Jones, E., Pallmann, P. and Euden, J. 2022. Antibiotic prescribing in hospitalized patients with COVID-19 as a function of inflammatory markers in wave 1 versus wave 2: a systematic review. Presented at: BSAC Spring Conference 2022, 10 - 11 May 2022, Vol. 4. Vol. S.2., (10.1093/jacamr/dlac053.012)
• Euden, J. et al. 2022. PROcalcitonin and NEWS2 evaluation for Timely identification of sepsis and Optimal use of antibiotics in the emergency department (PRONTO): protocol for a multicentre, open-label, randomised controlled trial. BMJ Open 12(6), article number: e063424. (10.1136/bmjopen-2022-063424)
• Euden, J. et al. 2022. Procalcitonin evaluation of antibiotic use in COVID-19 hospitalized patients during the first wave of COVID-19: the PEACH study. Presented at: Infection 2021: BSAC Winter Conference, Virtual, 9-10 December 2021, Vol. 4. Vol. 1., (10.1093/jacamr/dlac004.013)

2021

• Little, P. et al. 2021. Antibiotics for lower Respiratory Tract Infection in Children presenting in Primary Care (ARTIC PC): a randomised placebo controlled trial. The Lancet 398, pp. 1417-1426. (10.1016/S0140-6736(21)01431-8)
• Powell, N. et al. 2021. Use of procalcitonin during the first wave of COVID-19 in the acute NHS hospitals: a retrospective observational study. Antibiotics 10(5), article number: 516. (10.3390/antibiotics10050516)

2013

• Euden, J., Mason, S. and Williams, A. J. 2013. Functional characterization of the cardiac Ryanodine receptor pore-forming region. PLoS ONE 8(6), article number: e66542. (10.1371/journal.pone.0066542)
• Euden, J., Mason, S., Viero, C., Thomas, N. L. and Williams, A. J. 2013. Investigations of the contribution of a putative glycine hinge to ryanodine receptor channel gating. Journal of Biological Chemistry 288(23), pp. 16671-16679. (10.1074/jbc.M113.465310)

2012

• Mason, S., Viero, C., Euden, J., Bannister, M., West, D., Chen, S. R. W. and Williams, A. J. 2012. The contribution of hydrophobic residues in the pore-forming region of the ryanodine receptor channel to block by large tetraalkylammonium cations and Shaker B inactivation peptides. The Journal of General Physiology 140(3), pp. 325-339. (10.1085/jgp.201210851)
• Viero, C., Thomas, N. L., Euden, J., Mason, S. A., George, C. H. and Williams, A. J. 2012. Techniques and methodologies to study the ryanodine receptor at the molecular, subcellular and cellular level. In: Calcium Signaling. Advances in Experimental and Medical Biology Dordrecht: Springer, pp. 183-215., (10.1007/978-94-007-2888-2_8)
• Viero, C., Thomas, N. L., Euden, J., Mason, S., George, C. H. and Williams, A. J. 2012. Techniques and methodologies to study the ryanodine receptor at the molecular, subcellular and cellular level. In: Islam, M. S. ed. Calcium Signaling. Advances in Experimental Medicine and Biology Vol. 740. Dordrecht: Springer, pp. 183-215., (10.1007/978-94-007-2888-2_8)

2010

• Carney, J., Mason, S. A., Viero, C. and Williams, A. J. 2010. The ryanodine receptor pore: Is there a consensus view?. In: Serysheva, I. I. ed. Structure and Function of Calcium Release Channels., Vol. 66. Current Topics in Membranes Elsevier Academic Press In, pp. 49-67., (10.1016/S1063-5823(10)66003-6)

2007

• Carney, J., East, J. M. and Lee, A. G. 2007. Penetration of lipid chains into the transmembrane surface of TbMscL. Biophysical Journal 92, pp. 3556-3563. (10.1529/biophysj.106.102210)